Lumateperone as Adjunctive Therapy in Patients With Major Depressive Disorder and Anxious Distress: Post Hoc Analysis of a Phase 3, Randomized, Double-Blind Trial.
The Journal of clinical psychiatry · 2026
Abstract e pubblicazione originale
L’abstract è consultabile nella fonte originale. Non viene ripubblicato qui perché non risulta verificata una licenza compatibile.
Leggi nella fonte originale ↗Parole chiave
HumansMajor Depressive DisorderFemaleMaleDouble-Blind MethodMiddle AgedAdultDrug Therapy, CombinationAntidepressive AgentsPsychological DistressAdolescentAgedYoung AdultPsychiatric Status Rating ScalesPiperidinesTreatment OutcomeHeterocyclic Compounds, 4 or More Rings
Come citare questo studio
Gary S Sachs, Suresh Durgam, Willie R Earley, Susan G Kozauer, Changzheng Chen, Prakash Masand. (2026). Lumateperone as Adjunctive Therapy in Patients With Major Depressive Disorder and Anxious Distress: Post Hoc Analysis of a Phase 3, Randomized, Double-Blind Trial.. The Journal of clinical psychiatry. DOI: 10.4088/jcp.26m16409
Consulta la pubblicazione originale ↗